LegoChem Biosciences, Inc. (141080.KQ)

KRW 96700.0

(-6.84%)

Total Liabilities Summary of LegoChem Biosciences, Inc.

  • LegoChem Biosciences, Inc.'s latest annual total liabilities in 2023 was 41.28 Billion KRW , up 25.35% from previous year.
  • LegoChem Biosciences, Inc.'s latest quarterly total liabilities in 2024 Q2 was 114.34 Billion KRW , down -16.75% from previous quarter.
  • LegoChem Biosciences, Inc. reported annual total liabilities of 32.93 Billion KRW in 2022, down -4.43% from previous year.
  • LegoChem Biosciences, Inc. reported annual total liabilities of 34.45 Billion KRW in 2021, up 44.87% from previous year.
  • LegoChem Biosciences, Inc. reported quarterly total liabilities of 137.35 Billion KRW for 2024 Q1, up 232.74% from previous quarter.
  • LegoChem Biosciences, Inc. reported quarterly total liabilities of 34.44 Billion KRW for 2023 Q1, up 4.6% from previous quarter.

Annual Total Liabilities Chart of LegoChem Biosciences, Inc. (2023 - 2016)

Historical Annual Total Liabilities of LegoChem Biosciences, Inc. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 41.28 Billion KRW 25.35%
2022 32.93 Billion KRW -4.43%
2021 34.45 Billion KRW 44.87%
2020 23.78 Billion KRW -6.97%
2019 25.56 Billion KRW 55.98%
2018 16.39 Billion KRW -49.99%
2017 32.77 Billion KRW 11.13%
2016 29.49 Billion KRW 0.0%

Peer Total Liabilities Comparison of LegoChem Biosciences, Inc.

Name Total Liabilities Total Liabilities Difference
HLB Co., Ltd. 169.47 Billion KRW 75.642%
iNtRON Biotechnology, Inc. 1.88 Billion KRW -2095.37%
BINEX Co., Ltd. 75.68 Billion KRW 45.458%
Bioneer Corporation 80.61 Billion KRW 48.79%
Anterogen.Co.,Ltd. 19.98 Billion KRW -106.541%
MEDIPOST Co., Ltd. 135.73 Billion KRW 69.587%
CrystalGenomics, Inc. 97.82 Billion USD 57.8%
Helixmith Co., Ltd 73.55 Billion KRW 43.879%
Chabiotech Co.,Ltd. 1069.23 Billion KRW 96.139%
Medy-Tox Inc. 137.14 Billion KRW 69.899%
Peptron, Inc. 16.36 Billion KRW -152.19%
Amicogen, Inc. 248.12 Billion KRW 83.363%
Genexine, Inc. 79.68 Billion KRW 48.194%
HLB Therapeutics Co.,Ltd. 29.27 Billion KRW -41.006%
ALTEOGEN Inc. 108.25 Billion KRW 61.868%
PharmaResearch Co., Ltd. 73.08 Billion KRW 43.518%
SillaJen, Inc. 19.4 Billion KRW -112.778%
JETEMA, Co., Ltd. 179.09 Billion KRW 76.95%
OliX Pharmaceuticals,Inc 52.48 Billion KRW 21.353%
Genomictree Inc. 7.81 Billion KRW -428.412%
MedPacto, Inc. 9.56 Billion KRW -331.55%
D&D Pharmatech 23.98 Billion KRW -72.107%
EASY BIO,Inc. 105.86 Billion KRW 61.007%
GI Innovation, Inc. 9.63 Billion KRW -328.394%